CANCELED: f-TALES conference 'Opportunities and Challenges in Cancer Immunotherapy'

All info on the conference website

Immunotherapy is a fastly emerging field in cancer medicine. However, its results are not entirely positive. Moreover, scientists are still puzzled how to define responders and what biomarkers to use. This conference will highlight clinical successes and failures, the translational search for immune monitoring and new discoveries from basic science that might change our clinical management in the future. The conference will start with workshops focusing on frequently used techniques, like cellular therapies at the GMP level, FACS, CyTOF and single cell analysis. 

CRIG group leader prof. Karim Vermaelen is member of the organizing committee.